NFKB1 and osteosarcoma: Previous studies have also shown that dox treatment in MCF-7 cells caused drug resistance in a NF-κB dependent manner28 and that the inhibition of NF-κB activity could at least partially overcome dox-induced resistance in MCF-7 and human osteosarcoma cell lines19, 29.